Pharmaceutical Services
Page 1 • 3 itemsGain critical insights into global pharmaceutical services, CROs, CDMOs, and regulatory consulting. Drive your pharma BD strategy with expert analysis.
Phathom Pharmaceuticals VOQUEZNA Sales Surge 104% in Q1 2026, Company Maintains Profitability Guidance
Phathom Pharmaceuticals reports $58.3M Q1 revenue from VOQUEZNA, up 104% year-over-year, with 1.35M prescriptions filled and profitability expected Q3 2026.
Regeneron Q1 2026 Earnings: Dupixent Sales Surge 33% to $4.9B, EYLEA HD Shows Strong Growth
Regeneron reports 19% revenue growth to $3.6B in Q1 2026, driven by Dupixent's 33% sales increase to $4.9B and EYLEA HD's 52% growth to $468M.
Sun Pharma Acquires Organon for $11.75 Billion in Major Pharmaceutical Merger
Sun Pharmaceutical Industries announces $11.75 billion acquisition of Organon at $14 per share, creating global pharmaceutical powerhouse.